Patent · US Active

C/EBP alpha saRNA compositions and methods of use

US10912790B2 · kind B2 · utility

0Cited by

1References

23Claims

0Family size

Assignee

MiNA Therapeutics Limited · GB

Inventors

Andreas Wagner · Klosterneuburg, AT
Robert Habib · Geneva, CH
Hans E. Huber · Lansdale, US
Pål Sætrom · Trondheim, NO
Endre Bakken Stovner · Trondheim, NO
Markus Hossbach · Kulmbach, DE
Monika Krampert · Bamberg, DE
Hans-Peter Vornlocher · Bayreuth, DE

Key dates

Filing date	Apr 21, 2016
Grant date	Feb 9, 2021
Priority date	—
Expiry date	Jan 8, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/32
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to saRNA targeting a C/EBPα transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.